Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Orgenesis's Total Inventories for the quarter that ended in Mar. 2022 was $0.12 Mil. Orgenesis's Revenue for the
three
months ended in Mar. 2022 was $7.21 Mil.
Orgenesis's Inventory-to-Revenue for the quarter that ended in Mar. 2022 was 0.02.
Orgenesis's Inventory-to-Revenue for the quarter that ended in Mar. 2022
declined
from Dec. 2021 (0.02) to Dec. 2021 (0.02)
A decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Orgenesis's Days Inventory for the
three
months ended in Mar. 2022 was 14.76.
Total Inventories can be measured by Days Sales of Inventory (DSI).
Orgenesis's days sales of inventory (DSI) for the
three
months ended in Mar. 2022 was 1.46.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Orgenesis's Inventory Turnover for the quarter that ended in Mar. 2022 was 6.18.
Orgenesis Inventory-to-Revenue Historical Data
The historical data trend for Orgenesis's Inventory-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Orgenesis Annual Data
Trend
Nov12
Nov13
Nov14
Nov15
Nov16
Nov17
Nov18
Dec19
Dec20
Dec21
Inventory-to-Revenue
0.06
0.07
0.24
0.02
-
Orgenesis Quarterly Data
May17
Aug17
Nov17
Feb18
May18
Aug18
Nov18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Inventory-to-Revenue
0.02
0.02
0.02
0.02
0.02
Competitive Comparison
For the Biotechnology subindustry, Orgenesis's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Orgenesis Inventory-to-Revenue Distribution
For the Biotechnology industry and Healthcare sector, Orgenesis's Inventory-to-Revenue distribution charts can be found below:
* The bar in red indicates where Orgenesis's Inventory-to-Revenue falls into.
Orgenesis Inventory-to-Revenue Calculation
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Orgenesis's Inventory-to-Revenue for the fiscal year that ended in Dec. 2021 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
More Related Terms:
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Orgenesis's Days Inventory for the
three
months ended in Mar. 2022 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Orgenesis Inventory-to-Revenue Related Terms
Thank you for viewing the detailed overview of Orgenesis's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Orgenesis Inc is a part of the healthcare sector. It is a fully-integrated biopharmaceutical company focused on developing trans-differentiation technologies for diabetes and vertically integrating manufacturing that can optimize its abilities to scale-up its technologies for clinical trials and eventual commercialization. The group operates in two segments namely CDMO and POC. The company is also engaged in applying its disciplined execution to emerging technologies of other cell therapy markets in such areas as cell-based cancer immunotherapies and neurodegenerative diseases.
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
0.04(1.7%) Volume: 41,600 4:00PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NAS:ORGS has been successfully added to your 
